Leqembi could give Alzheimer’s patients more time, but road to treatment is long
Hannah Yoon | The Washington Post | Getty ImagesLeqembi, an Alzheimer's drug from Biogen and Eisai, is not a cure ...
Tag: Leqembi
Eisai Biogen Alzheimer’s drug Leqembi shows advantages over three years
The newly FDA approved Alzheimer's treatment Leqembi is ready at Abington Neurological Associates in Abington, PA., on Tuesday, November 7, ...
Biogen Eisai Alzheimer’s drug Leqembi rejected by European regulator
European drug regulators on Friday rejected the Alzheimer's treatment Leqembi from Biogen and Eisai, creating one other hurdle for the ...
Alzheimer’s drug Leqembi launch, Apple Vision Pro nausea
Good afternoon! The launch of the closely watched Alzheimer's drug Leqembi is off to a slow start.Still, demand for the treatment ...
Biogen drops Alzheimer’s drug Aduhelm to deal with Leqembi, others
The Biogen headquarters in Cambridge, Massachusetts, on Oct. 24, 2023.Vanessa Leroy | Bloomberg | Getty ImagesBiogen on Wednesday said it ...
Alzheimer’s drug Leqembi sales could also be slow at first: Analysts
Jay Reinstein, who suffers from Alzheimer's, receives an injection so he can have a PET scan at MedStar Georgetown University ...
FDA approves Alzheimer’s drug Leqembi from Eisai, Biogen
The Food and Drug Administration on Thursday fully approved the Alzheimer's treatment Leqembi, a pivotal decision that may expand access ...
FDA advisors review Alzheimer’s drug Leqembi for full approval
A panel of independent advisors to the Food and Drug Administration is meeting Friday to make a advice on whether ...
Leqembi could cost Medicare $5 billion per yr
The Alzheimer's drug Leqembi is seen on this undated handout image obtained by Reuters on Jan. 20, 2023.Eisai | ReutersThe ...
Medicare will cover Alzheimer’s treatment Leqembi after FDA approves
Chiquita Brooks-LaSure testifies before the Senate Finance Committee during her nomination hearing to be administrator of the Centers for Medicare ...
